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Abstract.  We have compared the intracellular  trans- 
port and subcellular distribution of MHC class II- 
invariant chain complexes in a wild-type HLA-DR3 
homozygous cell line and a mutant cell line,  T2.DR3. 
The latter has a defect in antigen processing and ac- 
cumulates HLA-DR3 molecules associated with an in- 
variant chain-derived peptide (CLIP) rather than the 
normal complement of peptides derived from endocy- 
tosed proteins.  We find that in the wild-type cells, 
CLIP is transiently associated with HLA-DR3 mole- 
cules,  suggesting that the peptide is a normal class 
H-associated intermediate generated during proteolysis 
of the invariant chain.  In the mutant cell line proteoly- 
sis of the invariant chain is less efficient, and HLA- 
DR3/CLIP complexes are generated much more 
slowly. Examination  of the mutant cell line by im- 
munoelectronmicroscopy shows that class II-invariant 
chain complexes accumulate intracellularly  in large 
acidic vesicles which contain lysosomal markers,  in- 
cluding fl-hexosaminidase, cathepsin D, and the 
lysosomal membrane protein CD63.  The markers in 
these vesicles are identical to those seen in the class 
II-containing vesicles (MIICs) seen in the wild-type 
cells but the morphology is drastically different. The 
vesicles in the mutant cells are endocytic, as measured 
by the internalization  of BSA-gold conjugates.  The im- 
plication of these findings for antigen processing in 
general and the nature of the mutation in particular 
are discussed. 
M 
AJOR histocompatibility  complex  (MHC)  ~ mole- 
cules present antigenic peptides to T cells during 
an immune response.  Class I molecules present 
peptides from cytosolic proteins to CD8+ T cells (Townsend 
and Bodmer,  1989), while class II molecules predominantly 
present peptides from exogenous proteins to CD4+ T ceils 
(Unanue,  1984). Intracellularly,  class 11 molecules associate 
with a third  protein,  the invariant  (I)  chain  (Jones et al., 
1979;  Machamer and Cresswell,  1982).  I chain  associates 
with class II heterodimers in the endoplasmic reticulum (ER) 
in a nine-chain  complex consisting  of a core I chain trimer 
with  three  associated heterodimers  (Marks  et  al.,  1990; 
Roche et al., 1991). This complex contains no detectable as- 
sociated antigenic  peptides  (Roche and  Cresswell,  1990; 
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Newcomb and Cresswell,  1993; Roche et al.,  1992). Once 
assembled, the ot/3I complex traverses the Golgi stacks and 
is sorted to a compartment that is both acidic and endocytic 
(Lotteau et al., 1990; Lamb et al., 1991; Bakke and Dobber- 
stein,  1990). The key signal for this sorting event resides in 
the cytoplasmic domain of the I chain (Bakke and Dobber- 
stein,  1990). In Epstein  Ban" virus (EBV)-transformed  hu- 
man  B-cell lines  this  compartment  has  been extensively 
characterized  by  electron  microscopy.  It  shares  features 
characteristic  of lysosomes, and has  been designated  the 
MHC-class H-containing  compartment  (MIIC)  (Peters  et 
al., 1991b). Biosynthetic studies of class II molecules in vivo 
have shown that I chain is proteolytically degraded, probably 
in this endocytic compartment (Blum and Cresswell,  1988; 
Nguyen et al., 1989), releasing otfl dimers which are compe- 
tent to bind antigenic peptides (Roche and Cresswell,  1991; 
Newcomb and Cresswell,  1993). Thus, the efficient degrada- 
tion and complete dissociation of I chain  is critical for the 
class II complex to fulfill its function of presenting  antigenic 
peptides to T cells. 
Maturation of class II molecules in vivo, dissociation of 
I chain,  and peptide binding  correlates with the acquisition 
of an SDS-stable phenotype for class II ot/~ dimers (Germain 
and Hendrix,  1991). HLA-DR3 molecules from cell lines 
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shown to be SDS-unstable (Mellins et al.,  1990;  Riberdy 
and  Cresswell,  1992).  Further,  the  class  II  molecules 
purified from two such mutant cell lines expressing HLA- 
DR3 lack a wild-type repertoire of  endogenously  bound pep- 
tides and are instead primarily associated with high levels of 
a  nested set of invariant chain-derived peptides  (class II- 
associated invariant chain-derived peptides  or  CLIP [Ri- 
berdy et al.,  1992;  Sette et al., 1992]).  Peptides generated 
from the same region of I chain have also been isolated from 
wild-type class II molecules indicating that such peptides are 
not solely generated in mutant cell lines (Chicz et al., 1992; 
Rudensky et al., 1991; Hunt et ai., 1992). Here we show that 
in wild-type cells HLA-DR3 or/3 dimers are transiently as- 
sociated with CLIP during intracellular transport. In con- 
trast,  the mutant cell line T2.DR3  accumulates ot/3CLIP 
complexes  during  biosynthesis  and  ultimately  expresses 
these complexes at the cell surface. Electron microscopy re- 
veals an accumulation of class II molecules in T2.DR3 cells 
in large vesicular compartments. These contain many of the 
markers characteristic of the class H-containing compart- 
ment seen in wild-type B-cell lines, but differ drastically in 
morphology. We propose that the defect in antigen process- 
ing in the mutant cells induces the accumulation of class II 
molecules in this compartment, and that this accumulation 
induces its distention. 
Materials and Methods 
Cell Lines 
The cell lines T1.DR3, T2.DR3,  and Pala have been previously  described 
(Riberdy  and Cresswell,  1992) and were cultured in Iscove's Duibecco's 
modified medium 0MDM, GIBCO BRL, Galthersburg, MD) with 5 % calf 
serum (CS, Gibco) at 37°C. 
Radiolabeling 
Continuous metabolic labels were performed as described (Machamer and 
Cresswell,  1982). Cells were preincubated in methionine-free DME, sup- 
plemented with L-glutamine, 3% dialyzed FCS, and 0.5% gentamicin (all 
from Gibco) for 1 h at 37°C.  Cells were then resuspended  in methionine- 
free medium described above and labeled at 37°C  with [35S]methionine 
trans-label (ICN, K & K laboratories, Inc., Plainview, NJ). For pulse-chase 
experiments,  cells were preincubated as  described above,  labeled with 
[35S]methioulne trans-label (ICN)  and chased  in IMDM  (G-ibco) sup- 
plemented with 5% calf serum, 0.5% gentamicin, and a 15-fold excess of 
cold methionine (Sigma Chem. Co., St.  Louis,  MO). 
Immunoprecipitations 
Metabolically labeled cells were extracted in 1% Triton X-100 (TX-100, 
Sigma Chem. Co.), 0.1 mM tosyllysine chloromethyl ketone (TLCK,  Sigma 
Chemical Co.) and 0.5 mM PMSF (Sigma Chem. Co.) in Tris-saline,  pH 
7.4 (TS, pH 7.4,  10 mM Tris and 0.15 M NaC1, both from Sigma Chem. 
Co.).  Extraction was performed on ice at 2  x  106 cells per ml for 30 rain 
with occasional agitation. Nuclei were pelleted at 1,000 g for 10 rain at 4°C. 
The lysate was clarified  by centrifugation for 10 min at 14,000 rpm in a 
microcentrifuge.  Supernatants were precleared with 2/~1 rabbit anti-human 
immunoglobulin and 30/~1 protein A-Sepharose  CL-4B (both from Sigma 
Chem. Co.) at 4°C for 1 h. Lysates were then incubated with specific anti- 
body for 1 h at 4°C and subsequently incubated for an additional hour with 
30 ~tl protein A-Sepharose at 4oc. The beads were then washed four times 
with 0.05%  TX-100 in TS, pH 7.4. 
One-Dimensional Gel Analysis 
SDS-PAGE was performed as described (Laemmli,  1970).  All gels con- 
tained a final concentration of 10.5% acrylamide and were 1.5-ram thick. 
Gels were fixed in 7.5% acetic acid and 5% MeOH for at least 30 rain, and 
then immersed for 30 min in 100 ml of Enlightnin$ (Dupont,  New England 
Nuclear,  Boston, MA) for fluorography,  before drying. 
Affinity Purification 
Metabolically labeled cells were lysed in 2 % polyoxyethylene 9 lauryl ether 
(C12 Eg, Sigma Chem. Co.), 03 mM TLCK, 0.5 mM PMSF, 5 mM iodo- 
acetamide, 0.02% NaN3 (all from Sigma Chem. Co.) in TS, pH 7.4 for 45 
rain on ice, with occasional  agitation.  Extraction concentration was  106 
cells per mi of lysis buffer. Nuclei were pelleted at 1,000 g, 4°C, and re- 
moved. The extract was further clarified by ultracentrifugetion  at 100,000 g 
for 1 h, 4°C.  HLA-DR3 molecules were purified by immnnoaflinity chro- 
matography, using a mouse immunoglobulin  precoluum connected in series 
to a L243 (HLA-DR specific mAb) affinity column as previously described 
(Riberdy et al.,  1992). The specific columns were then washed with 200 
ml of 0.5 % deoxycholate  (DOC) and 0.02 % NaN3 in TS, pH 8.0, reequili- 
brated in 1% N-octylglucoside  (Boehringer Mannheim, Indianapolis,  IN), 
0.02% NaN3 in TS, pH 8.0, and purified molecules were eluted with 0.1 M 
Tris,  pH  11.5, 1% N-octyglucoside  and 0.02%  NAN3. Immediately  after 
elution the fractions were neutralized by addition of 1 M acetic acid (Fischer 
Co., Pittsburgh, PA) and the peak radioactive fractious were pooled and 
stored at 4°C until use. For preparations to be analyzed by ~versed-phase 
HPLC,  0.1% Ct2E9 was used in the reequilibratlon and elution buffers in- 
stead of 1% N-octylglucoside. 
Separation of  Bound Peptides from Purified 
Class H Complexes 
Class II molecules  purified by aifinity chromatography were denatured by 
addition of acetic acid to a final concentration of 10%. The peptides  were 
immediately separated  by centrifugation through a Centricon 10 filtration 
unit (Amicon, Danvers, MA) at 7,000 rpm for 50 vain at room temperature. 
The ct- and/~-chains were retained above the filter. 
HPLC Analysis of Peptides 
Endogenous peptides purified as described above were analyzed by HPLC 
using a Delta-Pak analytical C18 column (Waters Chromatography Divi- 
sion, Milford,  MA). Peptide samples were adjusted to a final concentration 
of 0.1% hydrochloric acid (Pierce Chem. Co., Rockford, IL)and subjected 
to chromatography with the following gradient: 0 %-15 % acetonitrile from 
0-20 min and 15-45% acetonitrile from 20-120 min at a flow rate of 0.5 
ml/min. 
Tris-tricine Gel Electrophoresis 
Electrophoresis  conditions were performed as described by Shagger and von 
Jagow (1987). The stock acrylamide solution used in these experiments was 
designated by Shagger and yon Jagow as 49.5%% 3%C (48% acrylamide, 
1.5 % N,N-methylenebisacrylamide, Bio-rad Labs., Hercules,  CA). 1.5-cm 
stacker gel  was polymerized on top of 1.5-cm spacer gel and '~6.5-cm 
separating gel (using the separating gel recipe designated as 16.5 %% 3 %C). 
Both the spacer and separating gels were copolymerized.  Samples were run 
into the stacker gel at 30 V, and then run to the bottom of the gel at 60 V. 
Upon completion, gels were immediately placed in 100 nd of 10% MeOH, 
10% acetic acid, 5% glycerol and rocked for 30 rain at room temperature. 
Gels were briefly rinsed with H20 and placed in 100 ml of EnlighUfing  with 
5 % glycerol  added (rocking at room temperature for 30 rain). Gels were 
dried in two cycles with continuous vacuum as follows: 2.5 h with a slow 
increase in temperature to 60°C, and then 2 more h with a rapid rise in tem- 
perature to 80°C. 
Cell Surface Biotinylation 
Radiolabeled  cells were pulsed and chased as described above. At the end 
of the chase period, the cells were washed once in PBS and resuspended 
at 2  x  106 cells per ml in ice cold bicine-saline, pH 7.5 (BS,  130 mM 
NaC1,  20  mM  bicine,  Sigma  Chem.  Co.).  Sulfosuocinimidyl-6-(bi- 
otinamido) hexanoate  (NHS-LC-Biotin,  Pierce Chem. Co.) was added to 
a final concentration of 0.2 mM and the cells incubated for 30 rain on ice. 
The reaction was stopped by addition of I M glycine (Sigma Chem. Co.) 
to a final concentration of 10 mM and the cells pelleted by centrifugation, 
1,000 rpm, 10 min, 4°C. Pellets were stored at -20°C. Cells were then ex- 
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were washed four times with TS, pH 7.4, 0.05 % TX-100. Protein was eluted 
from the beads with 100 #1 of elution buffer, pH 11.5 (described above for 
affinity purification), for 5 min on ice. Supernatants were removed and neu- 
tralized by addition of 7 t~l  1 M acetic acid.  1 ml of 0.1%  C12E9 column 
buffer and BSA to a final concentration of 1% was added to each sample 
and biotinylated cell surface proteins were specifically precipitated by rock- 
ing at 4"C with avidin-agarose beads that had been precoated with FCS to 
prevent non-specific sticking. Pellets were washed four times with "IS, pH 
7.4, 0.05%  TX-100, and solubilized in 50 ml of tricine sample buffer, before 
analysis with Tris-tricine acrylamide gels. 
Electron Microscopy 
For studying the morphology, T1.DR3,  T2, and T2.DR3 cells were fixed in 
Karnovsky and embedded in Epon. Ultrathin sections were stained in uranyl 
Mg-acetate and Reynolds lead citrate. For immuno-electron microscopy, 
TI.DR3, T2, and T2.DR3 cells were fixed in a mixture of  2% paraforrnalde- 
hyde and 0.5 % glutaraldehyde (final concentrations) in 0.1 M sodium phos- 
phate, pH 7.4 for 2 h and shipped in 1% paraformaldehyde in the same buffer 
for further processing. Cell samples were embedded in 10% gelatin which 
was solidified on ice. Blocks were immersed in 2.3 M sucrose in phosphate 
buffer for 2  h  at 4"C and ultrathin cryosections were single and double 
immuno-labeled as described (Slot and Geuze, 1985; Slot et al., 1985) with 
10- and 15-nm protein-A conjugated colloidal gold probes. The antibodies 
used were rabbit antibodies against human cathepsin D (Geuze et al., 1988); 
human CD63 (Metzelaer et al., 1991); human class II (Peters et al., 1991b), 
DNP  (Dakopetts,  Glostrup,  Denmark);  CI-MPR  (Geuze et al.,  1988); 
I chain (Marks et al.,  1990),  and a mouse monoclonal antibody (PIN.l) 
against a  synthetic peptide corresponding to the cytosolic tail of I chain 
(Lamb and Cresswell, 1992). 
To study endocytic compartments, T1.DR3  and T2.DR3 were pulse in- 
cubated with 5-nm BSA/gold particles (OD, 10) for 10 rnin, and chased for 
0,  30,  60,  and  120  rain at  370C.  Endocytosis was  stopped in ice-cold 
medium and the cells were washed twice in cold medium to remove most 
of the surface-adhered gold. Cells were then fixed and processed as above. 
To detect acidic compartments at the EM level, T1.DR3  and T2.DR3 were 
incubated with 30 #M of the weak base 3-(2,4-dinitroanilino)-3-amino-N- 
methyldipropylamine, DAMP (Anderson et al., 1984) at 37"C for 30 rain 
and washed with ice-cold serum-free medium at 0*C for 4 min to remove 
cytoplasmic DAMP. The DAMP-treated cells were fixed and processed for 
immunogold labeling as above. 
Results 
Kinetics of Transport and Processing  of 
HLA-DR3 Molecules 
Class II molecules are posttranslationally modified by the 
addition of N-linked glycans in the ER. As the molecules tra- 
verse  the  Golgi,  the  oligosaccharides  are  trimmed  and 
modified (Machamer and Cresswell,  1982).  Sialic acid is 
added in the trans-Golgi and serves as a convenient marker 
for transport to the compartment. Previous studies of the 
biosynthesis of murine I-A  k molecules in T1 and T2 showed 
that sialylated class II-invariant chain complexes were gener- 
ated with similar kinetics in both parent and mutant cell lines 
(Riberdy and Cresswell,  1992).  Similar results have since 
been obtained in comparisons of DR3 transport in T2 and in 
wild-type cells (Cresswell, P., and J.  M.  Riberdy, unpub- 
lished results). We also previously showed that I-A  k mole- 
cules expressed in "1"2 cells were transported to a proteolytic 
comparmaent, since incubation of T2-I-A ~ cells in leupep- 
tin, a cysteine protease inhibitor, causes the accumulation of 
I chain fragments (leupeptin-induced proteins, or LIP) in as- 
sociation  with  I-A  k molecules  (Riberdy  and  Cresswell, 
1992).  LIP is produced by the partial inhibition of I chain 
proteolysis (Blum and Cresswell, 1988).  We have similarly 
found that LIP is produced in association with HLA-DR3 
molecules  in  leupeptin-treated  T2.DR3  cells  (Riberdy, 
J. M., unpublished results). The ultimate I chain proteolysis 
product in T2.DR3 cells, however,  is CLIP. 
When isolated from T2.DR3 cells, CLIP is comprised of 
a nested set of invariant chain-derived peptides 16-24 amino 
acids in length which are also found associated with a num- 
ber of class II alleles isolated from wild-type cell lines, sug- 
gesting that these peptides are naturally occurring breakdown 
products from proteolysis of the I chain (Chicz et al., 1992; 
Rudensky et ell., 1991; Hunt et al.,  1992).  The abnormally 
high levels  of CLIP association found with DR3  isolated 
from T2.DR3 (Riberdy et al., 1992) prompted us to examine 
the kinetics of CLIP generation and dissociation in T2.DR3 
and wild-type cells. Control Pala and mutant T2.DR3 cells 
were pulsed with [~sS]methionine for 30 rain and chased in 
the presence of 15-fold excess cold methionine for the indi- 
cated times. Cells were extracted and immunoprecipitated 
with the DR-specific monoclonal antibody L243.  Immuno- 
precipitates were analyzed on SDS-PAGE gels using tricine 
as the trailing ion to better separate small peptides in the 
1-5  kD range.  The sequence information on CLIP would 
predict a 2-3 kD peptide species. Fig. 1 shows a distinct band 
in that range that coprecipitates with class II molecules from 
both Pala and T2.DR3. In Pala cells the putative CLIP spe- 
cies is transiently associated with class 1I and then dissoci- 
ates during the later chase points. In contrast, the DR3 pre- 
cipitates from T2.DR3 show a striking accumulation of the 
same low molecular weight species. Interestingly, the puta- 
tive CLIP species  is not detected until 20 h  of chase in 
T2.DR3  cells,  suggesting that the rate of proteolysis of I 
chain in the mutant cells is slower. 
To confirm that the small peptide band seen in tricine gels 
is CLIP, Pala cells were labeled with [35S]methionine for 2 h 
and chased for 2, 4, or 24 h. DR3 molecules were affinity 
purified  and  associated  labeled  peptides  were  extracted, 
mixed with an unlabeled synthetic CLIP 24-mer, and sub- 
jected to reversed phase HPLC. The results are shown in Fig. 
2.  At 2  h,  three  late-eluting 35S-labeled peaks  are  seen, 
eluting at 78 min, 83 rain, and 87 rain, respectively. Three 
identical peaks were seen when peptides were similarly iso- 
lated from DR3 molecules isolated from [35S]methionine- 
labeled T2.DR3 cells chased for 18-24 h (data not shown). 
The 87-min  peak eluted coincidentally with the synthetic 
CLIP 24 mer (not shown), and the two earlier peaks are 
probably  truncated versions of CLIP,  previously seen  in 
T2.DR3 cells (Riberdy et al., 1992).  It is clear from Fig. 2 
that the levels of these peaks are considerably decreased at 
24 h, consistent with the tricine gel data shown in Fig.  1. 
As a further confirmation that the 2-3-kD band seen as- 
sociated with HLA-DR3 molecules by tricine electrophore- 
sis was CLIP, the three late-eluting [35S]methionine-labeled 
peaks, derived from T2.DR3 cells, were collected and ana- 
lyzed by Tris-tricine gel electrophoresis. The mobility of the 
purified radiolabeled peptides on a tricine gel was identical 
to CLIP coprecipitated with I-ILA-DR3  from T2.DR3  by 
L243 (Fig. 3). The tricine gel system presumably is incapa- 
ble of resolving the minor Mr differences between the in- 
dividual peptides. Finally, in an attempt to definitively show 
that the Pala-derived peaks were CLIP, the final peak (87 
min elution) was subjected to Edman sequencing and the in- 
dividual cycles collected and counted for 35S-content. The 
CLIP 24-mer has methionine residues at the 1  lth and 13th 
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of CLIP association.  Pala and 
T2.DR3  cells  were  labeled 
with  [~SS]methionine for  15 
min and chased in the pres- 
ence  of a  15-fold  excess  of 
cold methionine for the indi- 
cated times.  Immunoprecipi- 
tates  of  cell  extracts  were 
performed  with  a  negative 
control antibody GAP.A3  or 
an  anti-HLA-DR  antibody 
L243  and  subjected  to Tris- 
tricine  gel electrophoresis  as 
described  in  Materials  and 
Methods.  The arrowhead in- 
dicates  a  low  molecular 
weight  peptide  species  that 
coprecipitates with HLA-DR3 
and  was  later  identified  as 
CLIP (see below). 
positions (Riberdy et al.,  1992). 3sS was clearly obtained at 
the llth cycle, consistent with the pcptide lacing CLIP (data 
not shown). 35S was also present in the 13th cycle, although 
a  clear '~rough" with zero counts was not obtained on the 
12th  cycle.  This  may be  a  consequence of some contam- 
ination  with  a  pcptide  with  an  additional  residue  on  the 
NH2-terminus,  or  incomplete  cleavage on  the  11th  cycle. 
Nevertheless,  overall these data validate the pulse-chase ex- 














Figure 2. Identification  of CLIP during pulse-chase analysis.  Pala 
cells were labeled  for 2 h with [35S]methionine and chased in the 
presence of a 15-fold excess of cold methionine for 2, 4, and 24 h, 
respectively. Cell lysates were subjected to affinity chromatography 
with an L243 anti-HLA-DR affinity column. The peak radioactive 
fractions were pooled. Acetic acid was added to a final concentra- 
tion of 10%  and peptides  smaller than 10 kD were separated  by 
filtration through a Centricon 10 filter unit.  Synthetic CLIP 81-104 
(30 ~g) was added to the radioactive  pcptides  and the preparations 
were separated  by reversed phase HPLC. 30-s fractions were col- 
lected and assayed for psS]methionine  cpm in a liquid scintillation 
counter.  Absorbancc of the synthetic CLIP peptide  was monitored 
at 210 nm and eluted with a retention time equivalent to the radioac- 
tivity collected in the last radioactive peak. The profile from the 2-h 
chase is represented  by the dotted line,  that from the 4-h chase by 
the solid line, and that from the 24-h chase by the thick solid line. 
during  intraceUular  transport  and is transiently  associated 
with  class  II  complexes  in  wild-type  DR3-positive  cells, 
whereas ct/~CLIP complexes accumulate later during biosyn- 
thesis  in T2.DR3 cells. 
IntraceUular Distribution of Class H and I Chain 
The above biochemical analyses clearly demonstrated an al- 
teration in the proteolysis and/or dissociation of I chain dur- 
ing biosynthesis in the mutant cell line T2.DR3.  To deter- 
mine if this affected the intraceUular distribution of class II 
molecules and associated I  chain,  the cells  were examined 
Figure 3.  Purification  of radiolabeled  CLIP and Tris-tricine  gel 
electrophorcsis.  DR3  was purified  from [35S]methionine labeled 
T2.DR3,  denatured by addition  of acetic acid and peptides  sepa- 
rated by filtration  through a Centricon 10 filter unit and reversed 
phase HPLC. The fractions corresponding to the three individual 
radioactive  peaks in Fig. 4 were collected, lyophilizexi, and sub- 
jected to Tris-tricine  gel electrophorcsis. 
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graphs of T1.DR3 (Fig. 4), 12 
(Fig. 5), and 12.DR3 (Figs. 6 
and  7).  Cells  were  fixed in 
Karnovsky and embedded in 
Epon. Ultrathin sections were 
stained in uranyl Mg-acetate 
and Reynolds lead citrate. The 
12.DR3  show huge  vacu- 
oles with internal membrane 
sheets and vesicles (asterisks) 
and surrounded by numerous 
larger  vesicles,  which  were 
absent from TI.DR3 and T2. 
G, Golgi complex; M, mito- 
chondrion; N, nucleus; Bars, 
2/zm. 
by electron microscopy. For a wild-type control cell in these 
experiments T1.DR3,  a  DR3/~-transfectant of T1,  the  im- 
mediate parent of T2,  was used.  This cell expresses both 
DR3 and DR7, but like T2 cells, is a TxB hybrid and therefore 
a superior control to the Pala B-cell line for morphological 
studies. Figs. 4 and 5 show that TI.DR3 and "1"2  cells, respec- 
tively, have the same general morphology as that previously 
described in human B-cell lines (Peters et al., 199 lb). Com- 
parison of the control cell lines with mutant T2.DR3 ceils 
at low magnification reveals large, often irregularly shaped 
vacuoles with a diameter of up to 7 #m only in the mutant 
cells (see Figs. 4-7). Numerous internal vesicles and mem- 
brane sheets are seen within these distended vacuoles (Fig. 
7). Interestingly these structures are only found in I2 cells 
that have been transfected with DR3 genes and not in un- 
transfected I2 cells (see Fig. 5). While we have not examined 
other class H transfectants of T2 by electron microscopy, we 
have found swollen vesicles which contain I-A  k in T2.I-A  k 
cells  by  immunofluorescence  (Robbins,  N.,  unpublished 
data). Thus, the presence of such vesicles is not a peculiarity 
of DR3 molecules themselves or the particular transfectant 
used. 
In normal B-cell lines, most of the intracellular class II is 
present in MIICs which have typical lysosomai characteris- 
tics, i.e., contain lysosomal enzymes, lysosomal membrane 
proteins, lack marmose-6-phosphate receptors (MPR),  are 
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sections of T1.DR3 (Figs. 8- 
10) and of I2 (Fig.  11). Cells 
were fixed in 2 % paraformal- 
dehyde, 0.5% glutaraldehyde 
in 0.1  M  sodium  phosphate, 
pH 7.4 for 2 h and stored  in 
1% paraformaldehyde,  0.1  M 
sodium  phosphate,  pH  7.4. 
Cells were embedded in 10% 
gelatin,  solidified on ice and 
blocks were immersed in 2.3 M 
sucrose  in  phosphate  buffer 
for 2 h at 4°C. Ultrathin cryo- 
sections of TI.DR3 or T2 cells 
were labeled with gold parti- 
cles (either  10 ran or 15 nm) 
directly  conjugated  to  anti- 
bodies  against  ~-hexosamin- 
idase,  class  II  molecules, 
CD63,  and  I  chain,  respec- 
tively. T1.DR3 cells were in- 
cubated  with 30 mM DAMP 
at 37°C for 30 rain and washed 
with cold serum-free medium 
at 0°C for 4 min before immu- 
nogold labeling with anti-DNP 
antibodies  which  will  recog- 
nize  internalized DAMP  in 
acidic  compartments,  as  de- 
scribed above. Bars, 0.1  ~¢m. 
acidic  and  have a  late  position  in  the  endocytic  pathway 
(Peters et al.,  1991b).  To investigate the nature of MIICs in 
T2.DR3 cells, immunogold labeling with antibodies against 
class II or- and/~-chains, I chain and a number of lysosomal/ 
MIIC markers was performed on ultrathin eryosections of 
T2.DR3 cells, as well as the control cell lines T1.DR3 and 
I2. TI.DR3 cells contain typical MIICs with abundant inter- 
nal vesicles and membrane sheets (Figs.  8-10). The MIICs 
in  T1.DR3  cells  contain  the  lysosomal  enzymes  fl-hex- 
osaminidase (Fig. 8) and cathepsin-D (not shown), the lyso- 
somal membrane protein CD63 (Fig. 9), lack CI-MPR (not 
shown), are acidic as indicated by the accumulation of the 
weak  base  3-(2,4-dinitroanilino)-3-amino-N-methyldipro- 
pylamine, DAMP (labeled with an anti-DNP antibody, Fig. 
10), and contain abundant class II molecules (Figs. 8, 10, and 
17 inset). Interestingly, MIICs containing I chain were also 
evident in T2 cells, but lack the same distended morphology 
as the irregular vacuoles found in T2.DR3  cells (Fig.  11). 
The MIICs of T1.DR3 and T2 show variable labeling for the 
I chain cytoplasmic domain.  Some MIICs are strongly la- 
beled for I chain while others show hardly if any labeling 
(Fig. 9). Most of the I chain labeling is associated with the 
content or with membranes in it, whereas the limiting mem- 
branes of the MIICs in T1.DR3 (Fig. 9) and I2 (Fig.  11) are 
The Journal of Cell Biology, Volume 125, 1994  1230 Figures 12-14. Ultrathin cryosections ofT2.DR3. T2.DR3 cells were fixed and ultrathin cryosections  were prepared for immunogo|d labeling 
as described for Figs. 8-11. Sections were immunogold labeled  with antibodies  against j3-hexosamim'dase, CD63, DNP, and class )1 molecules, 
as indicated. Only small segments of the large MIICs are depicted illustrating the size differences between MIICs in T1.DR3 and I"2. Bars, 
0.1  /zm. 
Riberdy et  al. MHC  Class II  Molecules in an Antigen Processing Mutant Cell  1231 Figures 15-16. Ultrathin cryosections of T2.DR3. T2.DR3 cells were fixed and ultrathin cryosections were prepared for immunogold labeling 
as described for Figs. 8-11. Sections were immunogold labeled with antibodies against class H molecules and I chain, as indicated. The MIIC 
profile in Fig.  16 contains two dense granules. Bars, 0.1 #m. 
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I chain in MIICs in these experiments is probably because 
an antibody to the cytoplasmic tail was used, which can de- 
tect I chain after proteolysis of the lumenal region. Antibod- 
ies against the lumenal part of I chain only moderately label 
MIICs. 
In any aspect studied except morphology, the huge vacu- 
oles in T2.DR3 were characteristic of MIICs. Similar to the 
MIICs in T1.DR3, MIICs in "I2.DR3 were positive for/3-hex- 
osaminidase (Fig. 12), CD 63 (Fig. 13), lack CI-MPR (not 
shown), and are acidic (Fig. 14), illustrating their lysosomal 
nature. Additionally, the MIICs in T2.DR3 contained abun- 
dant class 1I molecules and I chain (Figs. 12-15,  17). I chain 
labeling in T2.DR3 was different from that in T1.DR3 in two 
aspects. First, MIICs in T2.DR3 contain a much larger frac- 
tion of  the intracellular I chain. Secondly, most of  the I chain 
in T2.DR3 was associated with the limiting membrane of the 
MIICs rather than with the content as in TI.DR3 (Fig. 9) and 
"I"2 (Fig. 11). I chain labeling using antibodies to either cyto- 
plasmic or lumenal domains was absent from the cell sur- 
face. The MIICs in TI.DR3 and I2 were often connected to 
and surrounded by tubules that label for I chain (Fig.  11). The 
large vacuoles in 12.DR3 lack the tubules but are instead ac- 
companied by numerous larger vesicles (Fig. 6). 
In favorably contrasted sections the lumenal face of the 
MIIC membranes, in particular of the limiting membrane, 
showed an electron dense layer (Fig. 16) which was less ap- 
parent in T1.DR3  and T2. Furthermore, MIICs in T2.DR3 
contained electron dense globules (Figs. 14 and 16), which 
are reminiscent of those in the secretory lysosomes of cyto- 
toxic T-cells  (Peters et al.,  1990, 1991a). 
The position of MHCs in the endocytic pathway was stud- 
ied by pulse-chase incubation of both T2.DR3 and T1.DR3 
cells  with  5-nm  BSA/gold  particles  for  10+0,  10+30, 
10+60, and 10+120 rain. Only a few endocytosed particles 
could be detected in the MHCs in I2.DR3 after 10+30 rain 
(Fig.  17), whereas in T1.DR3 the MIICs already contain 
many particles after this period of endocytosis (see inset of 
Fig. 17). This is somewhat earlier than found previously in 
the B-ceU line JY where BSA/gold reaches MIICs only after 
60 min (Peters et al., 1991b). Thus, the microscopy studies 
show that T2.DR3 cells contain extraordinarily large, acidic 
MIICs with normal marker characteristics in which class II 
molecules and I chain seem to accumulate, and which are 
positioned late in the endocytic pathway. 
CLIP Peptides at the Cell Surface 
Fig.  1 demonstrates that CLIP accumulates with class 1I 
molecules in 12.DR3.  It was unclear if otBCLIP primarily 
accumulates in the endosomal compartment defined by elec- 
tron microscopy or whether ot/~CLIP was also found at the 
cell  surface.  Pala  and  "I2.DR3  cells  were  labeled  with 
[35S]methionine for 6 h and chased in the presence of 15- 
fold excess of cold methionine for 3 and 20 h, respectively. 
At the end of each chase period, the cell surface proteins 
were biotinylated with NHS-LC-biotin,  a  membrane im- 
permeable  reagent  reactive  with primary  amino  groups. 
Duplicate samples were extracted and immunoprecipitated 
with a negative control mAb (GAP.A3), an anti-I chain an- 
tiserum  that  exclusively  recognizes  intracellular  I  chain 
(R.p35N), or an anti-DR monoclonal antibody (L243). One 
set of samples was analyzed by Tris-tricine electrophoresis 
as a control for the total amount of protein precipitated by 
the individual antibodies. Both the R.p35N and L243 sam- 
pies showed significant amounts of protein precipitated with 
each antibody (data not shown). The remaining set of sam- 
pies were eluted from the protein A beads by alkaline elution 
(pH 11.5) and the supernatants were neutralized by addition 
of acetic acid before dilution with 10-fold excess lysis buffer. 
The cell surface proteins were then specifically precipitated 
with avidin-agarose beads and the samples were analyzed on 
Tris-tricine gels. Fig. 18 clearly shows that cell surface DR3 
complexes isolated from T2.DR3 molecules are associated 
with CLIP, while DR3 molecules from the Pala sample do 
not contain CLIP. The lack of avidin-precipitable protein 
bands isolated from the anti-p35N precipitates shows that the 
technique is  not recognizing intracellular proteins.  Thus, 
CLIP is found at the cell surface in T2.DR3 cells, while wild- 
type Pala cells do not express ot/~CLIP at the cell surface in 
amounts detectable by this procedure. 
Discussion 
The data described in this paper argue that the early stages 
of class II-invariant chain complex assembly and transport 
are similar in 12.DR3 and wild-type cells. After assembly 
the complexes are transported through the Golgi. In wild- 
type B-cell lines and in the parental hybrid T1.DR3, the class 
II-invariant chain  complexes are  then  delayed in  transit, 
probably in MIIC, the prelysosomal or lysosomal compart- 
ment previously defined by electron microscopy. In T2.DR3 
cells the dominant pool of intracellular class II molecules is 
found in the large multivesicular compartments described in 
this paper. These vacuoles contain the same complement of 
markers as the previously defined MIIC, and are like wild- 
type MIIC except for their morphology. We consider the 
most likely explanation for their origin to be that they repre- 
sent MIIC which are swollen and distended. Presumably this 
gross morphological change is a consequence of the muta- 
tion in the T2.DR3 cell line responsible for defective antigen 
processing. 
The  normal  proteolysis  of invafiant chain  is  severely 
affected in "I2.DR3 cells. The pulse-chase studies shown in 
Fig. 1 demonstrate this clearly. In the wild-type cells a num- 
ber of lower molecular weight class H-associated bands ap- 
pear during the chase which are characteristic of a protein 
undergoing progressive proteolytic degradation, and these 
bands are presumably fragments of  the invariant chain. It has 
previously been shown that oL/3  dimers associated with LIP, 
a leupeptin-induced partial proteolytic fragment of the invar- 
iant chain retaining the cytoplasmic domain, are reactive 
with L243, the mAb used for these experiments (Blum and 
Cresswell,  1988).  One of the bands has an Mr similar to 
that of a previously described 11-kD I chain fragment (Ngu- 
yen et al.,  1989).  Between 2--4 h  the lowest Mr fragment 
transiently appears. We have characterized this as CLIP, a 
nested set of I chain-derived peptides from residues 81-104 
(Figs. 2 and 3).  Since CLIP acts as a competitive inhibitor 
of antigenic peptide  binding  (Riberdy  et  al.,  1992),  the 
removal of this peptide from class II molecules is presum- 
ably essential for antigen presentation to occur. Its ultimate 
disappearance  from DR3  molecules in the wild-type cell 
Riberdy et al. MHC Class I1 Molecules in an Antigen Processing Mutant  Cell  1233 Figure 17.  Ultratlfm  cryosections  of T2.DR3 and T1.DR3 (inset).  T1.DR3 and T2.DR3  cells were pulse incubated  with BSMgold particles 
for 10 rain and chased  for 30 min at 37°C.  Endocytosis  was arrested  by cooling the cells with 4°C medium and excess gold that may have 
adhered to the cell surface was extensively washed away. Note that only a few particles  (arrowheads)  had reached the MIICs in T2.DR3  in 
contrast  to T1.DR3, which  shows numerous  endocytosed  particles  in the MIIC at this time.  Bars,  0.1/zm. 
The Journal of Cell Biology,  Volume 125, 1994  1234 Figure 18. Identification  of cell surface  CLIE Pala and T2.DR3 cells 
were labeled with [35S]methionine for 6 h and chased in the pres- 
ence of a 15-fold  excess of cold methionine  for 3 and 20 h, respec- 
tively At the end of each chase point, the ceil surface proteins were 
biotinylated with the amino-reactive biotin derivative, NHS-LC- 
biotin. Duplicate  cell extracts were immunoprecipitated  with a nega- 
tive control antibody, GAP.A3, an antibody recognizing  only intra- 
cellular p35 I chain, R.Ip35N, or an HLA-DR specific antibody 
L243. One set of immunoprecipitates  was subjected  to Tris-tricine 
gel  electrophoresis (data not  shown). The  other  set  of  im- 
munoprecipitates were eluted off the protein A-Sepharose beads by 
alkaline elution, pH 11.5. Eluates were neutralized  by addition of 7 
ml 1 M acetic acid and diluted to 1 ml in 0.1% Cz2E9 column buffer. 
Cell  surface proteins were specifically precipitated with avidin- 
agarose beads and subjected to Tris-tricine gel electrophoresis. 
probably reflects the loading of antigenic peptides and the ac- 
quisition of an SDS-stable phenotype for a large proportion 
of them. In the 12.DR3 cells, the fragmentation pattern of 
invariant chain is radically different, and CLIP is generated 
at a much slower rate. The slow generation of CLIP is con- 
sistent with the observed accumulation of I chain in T2.DR3 
vesicles relative to TI.DR3 M1/C (Figs. 15 and 16). Despite 
the  differences  in  the  degradation  pattern  of I  chain  in 
"12.DR3 cells, CLIP is ultimately generated. However, CLIP 
does not efficiently dissociate during biosynthesis (Fig.  1). 
The inability to efficiently  eliminate CLIP may be associated 
with the inability to properly load antigenic peptide in the 
enlarged M1/C compartment. 
Degradation of the invariant chain resulting in removal of 
the cytoplasmic domain is probably required for the delivery 
of  mature c~/3  dimers to the cell surface (Blum and Cresswell, 
1988; Neefjes and Ploegh, 1992). It has been argued that the 
invariant chain contains an endosomal retention signal in the 
cytoplasmic domain as well as a targeting signal (Bakke and 
Dobberstein, 1990). Ploegh and co-workers have also shown 
that DR molecules associated with LIP are not transported 
from the endosomal system to the plasma membrane (Neef- 
jes and Ploegh,  1992).  Thus,  a  reduced rate of invariant 
chain degradation would be expected to result in prolonged 
retention of class II molecules in the endosomal system. We 
have attempted by various techniques to precisely determine 
the transit time from ER synthesis to the plasma membrane 
for DR3 molecules in 12.DR3 but have been unsuccessful. 
In wild-type Pala cells, using a cell surface biotinylation ap- 
proach, we were able to detect some DR3 molecules on the 
cell surface within 30 min, with complete transport in 2--4 h 
(data not shown). This is somewhat faster than has been pre- 
viously seen  in  other  B-cell  lines  (Cresswell  and  Blum, 
1988).  In similar experiments we could not detect any cell 
surface expression in 12.DR3  within 8 h. Cell surface ex- 
pression is clearly detectable at 24 h (Fig.  18), but we have 
not quantitated the  percentage  of the  class  1/  molecules 
which successfully complete the journey from the ER. Over- 
all, the data argue that class 1/expression on the cell surface 
is delayed in T2.DR3 relative to wild-type cells, that the de- 
lay probably results from a reduced rate of invariant chain 
proteolysis, and that the class II accumulates in the vacuoles 
defined by electron microscopy which have characteristics of 
M1/C but are morphologically dramatically different. 
The precise reason for the generation of the large vesicles 
in T2.DR3 is unknown. It is conceivable that they enlarge 
simply because class II-invariant chain complexes accumu- 
late in them, as has been proposed to occur in transfected 
cell  lines  expressing  invariant  chain  (Romagnoli  et  al., 
1993). The presence of class 1/is clearly necessary since un- 
transfected I2 cells which have I  chain, but lack class 1/ 
genes, do not contain distended M1/C. This would argue that 
the enlarged MIIC are not merely a general defect, but are 
specifically associated with the accumulation of  class II mol- 
ecules within that compartment. The swollen MIIC cannot 
be due to a  simple defect in acidification as imrnunogold 
labeling with DNP clearly shows that the compartment is 
acidic (Fig.  10).  Presumably, enlarged vesicles containing 
exclusively I chain do not occur in untransfected T2 cells be- 
cause I chain, without class 1/molecules, predominantly re- 
mains in the ER (Marks et al.,  1990;  Lamb and Cresswell, 
1992).  The small number of normal M1/Cs in 12 (Fig.  11) 
may result from the very small fraction of invariant chain 
(933  homotrimers)  which  successfully  escapes  the  ER 
(Lamb and Cresswell, 1992).  The fact that M1/Cs form in 
12 argues that their formation is independent of class 1/ex- 
pression, and suggests that the invariant chain itself may be 
responsible for generating the structure. 
At least two plausible explanations exist to explain the in 
vivo association of CLIP with class 1/molecules derived 
from wild-type cells.  One is that CLIP is a  free peptide 
generated during the  proteolysis of I  chain which  has  a 
significant binding affinity for a  range of class 1/alleles. 
Class II binding peptides generated from the normal com- 
plement of exogenous proteins  would then compete with 
CLIP for the binding cleft of  the newly liberated or/3 heterodi- 
mer. Incomplete competition would result in some o~B-CLIP 
complexes being formed. Alternatively, CLIP could remain 
as a residual-associated fragment of  I chain after its proteoly- 
sis. This could be a region of the I chain in contact with c~/3 
dimers  in  otBI complexes,  bound  in  the  peptide-binding 
groove in the same manner as a conventional peptide. Induc- 
tion of CLIP dissociation by unknown mechanisms would 
then be required to generate oeB dimers competent to bind 
peptide. If the dissociation was incomplete, ,B-CLIP corn- 
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cate  that  CLIP is generated during the biosynthesis  of class 
II  molecules, is  transiently  associated  with the class  II  com- 
plex,  and dissociates  at  later  time points.  This result  is  prob- 
ably  more consistent  with CLIP remaining as  a  residual  class 
H-associated fragment  after invariant chain proteolysis. 
Whatever mechanism is  responsible  for inducing CLIP dis- 
sociation  and/or binding cndocytically  generated peptidcs  is 
presumably defective  in  T2.DR3 and may bc associated  with 
the distention  of the MIIC in that  cell  line. 
To  draw any conclusions  about the  kinetics  of  CLIP gener- 
ation and association in wild-type cells,  it was crucial  to 
show that  the smallest  molecular weight band seen in Fig. 
1 was CLIP. The purification  of metabolically labeled  class 
H-associated peptidcs  from T2.DR3 and Pala cells  that  had 
been pulsed and chased showed that  at  least  one of  the pep- 
tide peaks from the reversed phase HPLC  profiles  comi- 
grated precisely  with non-labeled synthetic  CLIP, and this 
peak had a methionine residue  in  the  expected 11th  position. 
The synthetic  24-mer used was the  longest  of  the CLIP pep- 
tides  that  were originally  sequenced (Riberdy et al., 1992) 
and the last to be cluted from the C18 column.  Thus, 
cornigration  with the  last  radioactive  peak is  expected. Also, 
the original  steady state  profiles  of  endogenous peptides  as- 
sociated  with DR3 from T'2.DR3 showed four  distinct  pep- 
tide  peaks, all  containing  a CLIP derivative.  Thus, the  char- 
acteristic profile of multiple radiolabeled pcptide peaks 
associated with class  II molecules purified  from Pala and 
T2.DR3 is consistent  with all peaks containing CLIP. The 
fact  that  the radioactive samples generate chromatograms 
containing three  peaks instead  of the four  peaks previously 
observed is most likely  duc to a loss  in resolution  because 
the radioactive  peaks arc actually collected fractions,  not 
continuous absorbance readings. Together, these data con- 
firm that  the labeled  peptidcs seen on Tris-tricine  gels  that 
arc associated  with the class  II molecules in T2.DR3 and 
Pala arc CLIP and thereby validate  the pulse-chase experi- 
ment examining the kinetics  of CLIP generation. 
CLIP is clearly  associated  with surface  DR3 in T2.DR3 
(Fig. 18).  The apparent lack  of CLIP associated  with the 
class  II  complexes at  the cell  surface  in Pala suggests  that  in 
wild-type  cells  CLIP may dissociate  before  arrival  at  the  ccU 
surface.  The obvious extension  of  these  observations  is  that 
in  wild-type  cells,  class  II  molecules bind  endocytic  peptidcs 
and/or simultaneously dissociate  from CLIP before  their  ar- 
rival  at the cell  surface.  We have previously shown that  an 
acidic  pH facilitates  the binding of an antigenic  peptidc to 
DIL3 molecules purified  from T2.DR3, consistent  with this 
occurring in an endosomal compartment.  However, CLIP 
dissociation  fails  to  occur in  T2.DR3 in  vivo,  suggesting  that 
acidification  is not the only requirement. Also,  the level  of 
sensitivity  of the biotinylation  assay used to determine the 
lack  of  CLIP at  the  cell  surface  is  uncertain  and a small  per- 
centage of c~B dimers at the cell  surface in wild-type cells 
could contain CLIP. The results  shown in Fig. 18 do show, 
however, that  CLIP dissociation  is not an absolute  require- 
ment  for transport of HLA-DR3  molecules  to the cell 
surface. 
Recent reports by Romagnoli et al.  (1993)  suggest that 
there may well be more than one post-Golgi compartment 
that class II molecules traverse during biosynthesis in which 
antigen processing is facilitated. These data suggest that cer- 
tain events such as complete and efficient  invariant chain pro- 
teolysis or antigenic peptide loading may need to occur in 
order to have efficient  transport to the next biosynthetic com- 
partment. Since T2.DR3 cells do not process and present an- 
tigenic proteins well, nor do they bind a normal repertoire 
of  peptides intraceUularly, it is reasonable to propose that the 
defect in these cells is in accessibility to peptides.  MIICs 
have been shown to be part of both the biosynthetic pathway 
of class II molecules and the endocytic pathway,  and are 
probably positioned at the intersection of these routes (Neef- 
jes et ai.,  1992).  They contain hydrolytic enzymes and are 
acidic and are therefore candidates for a  compartment in 
which antigen is processed and peptide is loaded on to the 
class II molecules. Indeed, recent studies on macrophages 
have shown that antigenic peptides are efficiently generated 
and may be loaded on to class II molecules in a late endocytic 
compartment with characteristics of MIIC (Harding et al., 
1991; Harding and Geuze,  1993).  How MIIes are formed 
from post-Golgi intermediates has not yet been elucidated. 
It is not known in what type of vesicles o~BI complexes exit 
the Golgi en route to the next station in transport, presum- 
ably the MIIC. The absence of small tubules and vesicles 
normally present around MIICs and the accumulation of 
larger vesicles (see Fig. 6) in T2.DR3 may reflect a defect 
in the formation of MIIes resulting in an improper sorting 
of class II complexes to the compartment where endocyti- 
cally generated peptides reside.  Conversely, there may be 
defects in transporting peptides to the compartment where 
the  liberated  class  II  (x/~ dimers  reside.  Any  of  these 
scenarios could result in the accumulation of class II mole- 
cules in MIIC and ultimately a defect in class II antigen pre- 
sentation. Further investigation of the processes involved in 
dissociating  CLIP and binding  peptide  in  the  MIIC  are 
needed to determine the mechanisms which generate the dis- 
tended MIIC in these cells. 
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